Texas Medical Center
Houston, TX 77030
Stacey L. Berg, MD
Dr. Stacey Berg is a pediatric oncologist specializing in the development of new anticancer drugs for children. She also has a strong interest in clinical trial design, biomedical ethics, and the incorporation of palliative care principles into pediatric oncology practice.
Dr. Stacey Berg’s primary research interest is in the design and conduct of early phase clinical trials of new anticancer agents. This process includes the evaluation of new agents against pediatric cancer targets in the laboratory, as well as preclinical pharmacokinetic studies. With these data, phase 1 studies are designed to determine the appropriate dose and schedule of new agents for use in children, as well as to obtain preliminary indications of activity. These results form the basis of subsequent larger scale clinical trials.
Medically Speaking: Cancer Clinical Trials, Stacey L. Berg, MD
Relapse & Developmental Therapeutics
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.